Toshikatsu Tamai
Kanazawa University
11 Papers
10 Citations
Toshikatsu Tamai is an academic researcher from Kanazawa University. The author has contributed to research in topics: Immune system & Immunotherapy. The author has an hindex of 5, co-authored 7 publications. Previous affiliations of Toshikatsu Tamai include University of Toyama.
Chat about Author
Papers
Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8+ T cells
Eishiro Mizukoshi,Hidetoshi Nakagawa,Toshikatsu Tamai,Masaaki Kitahara,Kazumi Fushimi,Kouki Nio,Takeshi Terashima,Noriho Iida,Kuniaki Arai,Tatsuya Yamashita,Taro Yamashita,Yoshio Sakka,Masao Honda,Shuichi Kaneko +13 more
TL;DR: This article showed that peptide-specific long-lasting CD8+ T cells acquire an effector memory phenotype that associates with cell cycle-related genes (CCNA2 and CDK1), and are characterized by high expression of IL7R, SELL, and NOSIP along with a later stage promotion of the AP-1 transcription factor network (5 years or more past vaccination).
25
Immune responses against tumour-associated antigen-derived cytotoxic T lymphocyte epitopes in cholangiocarcinoma patients.
Akihiko Kida,Eishiro Mizukoshi,Toshikatsu Tamai,Takeshi Terashima,Masaaki Kitahara,Kuniaki Arai,Tatsuya Yamashita,Kazumi Fushimi,Masao Honda,Shuichi Kaneko +9 more
TL;DR: This work compared cytotoxic T lymphocyte responses against several tumour‐associated antigen (TAA)‐derived epitopes in cholangiocarcinoma patients to identify candidate epitopes for immunotherapy.
15
Immune response to human telomerase reverse transcriptase-derived helper T cell epitopes in hepatocellular carcinoma patients
Masashi Kumagai,Eishiro Mizukoshi,Toshikatsu Tamai,Masaaki Kitahara,Tatsuya Yamashita,Kuniaki Arai,Takeshi Terashima,Noriho Iida,Kazumi Fushimi,Shuichi Kaneko +9 more
TL;DR: The purpose of the present study was to identify major histocompatibility complex class II‐restricted helper T cell epitopes derived from human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
12
Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET
Takayoshi Shirasaki,Satoshi Yamagoe,Tetsuro Shimakami,Kazuhisa Murai,Ryu Imamura,Kiyo-aki Ishii,Hiroaki Takayama,Yukako Matsumoto,Natsumi Tajima-Shirasaki,Naoto Nagata,Ryogo Shimizu,Souma Yamanaka,Atsushi Abe,Hitoshi Omura,Kazunori Kawaguchi,Hikari Okada,Taro Yamashita,Tomoki Yoshikawa,Kazuhiro Takimoto,Motoko Taharaguchi,Shogo Takatsuka,Yoshitsugu Miyazaki,Toshikatsu Tamai,Yamato Tanabe,Makoto Kurachi,Yasuhiko Yamamoto,Shuichi Kaneko,Kunio Matsumoto,Toshinari Takamura,Masao Honda +29 more
TL;DR: This paper showed that leukocyte cell-derived chemotaxin 2 (LECT2), a hepatokine and ligand of the MET receptor tyrosine kinase is an antiviral regulator that promotes the RIG-I-mediated innate immune response.
Interdisciplinary groups perform better than intradisciplinary groups in online group discussion activities.
Taro Yamashita,Shuji Osawa,Kunio Ota,Takahiro Minami,Yuma Morisaki,Yutaro Takahashi,Tomoya Itatani,Satoshi Hara,Toshikatsu Tamai,Makoto Fujiu,Hideki Nomura,Rie Okamoto +11 more
TL;DR: In this article, the authors evaluated the utility of online group work in interprofessional education for health-care pre-licensure learners during the novel coronavirus disease 2019 pandemic using an online video conferencing system.
7